Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

NCT06974617 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Sphenopalatine Block
BOTOX
Chronic Migraine

Interventions

DRUG: Sphenopalatine block
DRUG: Botulinum Toxin Type A

Sponsor

Cairo University